Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Ningbo
Clinical trial register · China

Clinical Trials in Ningbo, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19187 matching records held by the registry are in this view. Synced 08 Nov 2026, 03:17 UTC
19187
Studies in scope
all four open statuses
11790
Recruiting now
open to new participants
2028
Lead sponsors
across recruiting studies
Top sites
Ningbo 8 Hangzhou 1
Narrow the registerReset
Recruitment status
Phase
Site location
Ningbo8 Hangzhou1
All 2 locations
Target enrolment
to

Trials with a site in Ningbo

8 of 19187 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Ningbo No. 1 Hospital
Not applicable
106
Ningbo
2026-07-20
Recruiting
Accelerated Biological Aging is Associated With Increased Risk of T2DM in the MASLD Population
NCT06984510Type 2 Diabetes Mellitus (T2DM), Metabolic Dysfunction-Associated Steatotic Liver Disease, Biological Age
Ningbo No. 1 Hospital
Observational
2,720
Ningbo
2025-04-01
By invitation
Metabolically Healthy Obesity Increases the Risks of MASLD and Hyperuricemia
NCT07001865Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolically Healthy Obesity, Hyperuricemia
Ningbo No. 1 Hospital
Observational
17,040
Ningbo
2025-04-01
Active, closed
Screening and Intervention of MASLD in Children
NCT06905795MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease, Children
Ningbo No. 1 Hospital
Not applicable
270
Ningbo
2025-04-01
Recruiting
Comparing Different Diameter fURSs With Similar RESDs for the Treatment of Upper Urinary Tract Stones
NCT06987760Ureter Injury, Urolithiasis; Lower Urinary Tract, Efficacy, Self
Ningbo No. 1 Hospital
Not applicable
206
Ningbo
2025-03-19
Recruiting
Ningbo No. 1 Hospital
Phase 1
24
Hangzhou, Ningbo
2022-12
Active, closed
Ningbo No. 1 Hospital
Not applicable
1,627
Ningbo
2022-09-01
Active, closed
Ningbo No. 1 Hospital
Not applicable
331
Ningbo
2022-09-01
Rows per page Showing 1–8 of 8
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 9 November 2026. https://priyalifescience.com/clinical-trials-china/city/ningbo

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,187 studies in total at the last sync on 08 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 8 of those studies with a site in Ningbo that also match the filters currently applied.

How many clinical trials are recruiting in Ningbo?

3 of the 8 studies on this page are recruiting new participants as of the 08 Nov 2026, 03:17 UTC sync. A further 1 have not yet opened recruitment, 3 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Ningbo), 8 studies
PhaseStudiesRecruitingShare
Not applicable5162.5%
Observational2125%
Phase 11112.5%

Most active sponsors

Lead sponsors with the most studies (Ningbo)
Lead sponsorStudiesRecruiting
Ningbo No. 1 Hospital83
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.